Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus

scientific article published on 10 January 2012

Angiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/EN.2011-1764
P932PMC publication ID3281527
P698PubMed publication ID22234465

P50authorRichard D WainfordQ56911165
Patrice DelafontaineQ37387470
Tadashi YoshidaQ39992835
Sergiy SukhanovQ41174548
P2093author name stringDaniel R Kapusta
Laura Semprun-Prieto
P2860cites workAMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamusQ28254114
Central nervous system control of food intakeQ29547439
Role of neuropeptides in appetite regulation and obesity--a review.Q30356494
AMPK is essential for energy homeostasis regulation and glucose sensing by POMC and AgRP neuronsQ30479831
IGF-1 prevents ANG II-induced skeletal muscle atrophy via Akt- and Foxo-dependent inhibition of the ubiquitin ligase atrogin-1 expressionQ33840703
Candesartan cilexetil: an angiotensin II-receptor blockerQ33901315
Mechanisms of cancer cachexiaQ34016887
Biology of cachexiaQ34065627
The syndrome of cardiac cachexiaQ34774425
Angiotensin II induced catabolic effect and muscle atrophy are redox dependentQ35028013
Neuropeptides, food intake and body weight regulation: a hypothalamic focusQ35048780
Angiotensin II upregulates protein phosphatase 2Cα and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wastingQ35240148
Hypothalamic control of energy balance: different peptides, different functionsQ35769125
Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndromeQ35886214
Molecular-specific effects of angiotensin II antagonists: clinical relevance to treating hypertension?Q36223165
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.Q36248631
WITHIN-PATIENT VARIABILITY OF HORMONE AND CYTOKINE CONCENTRATIONS IN HEART FAILUREQ57628891
Activation/deactivation of renal Na+,K(+)-ATPase: a final common pathway for regulation of natriuresisQ72387481
Characterisation of 5'-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5'-AMP analogues on enzyme activityQ72425499
Abnormal hemodynamics and elevated angiotensin II plasma levels in polydipsic patients on regular hemodialysis treatmentQ72889565
Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failureQ73301653
Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor IQ73620065
Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinasesQ78036425
Neuroendocrine control of food intakeQ80151225
From genetics to mechanism of disease liabilityQ80930874
Protection from angiotensin II-mediated vasculotoxic and hypertensive response in mice lacking PI3KgammaQ36403518
Angiotensin II as candidate of cardiac cachexiaQ36445136
Intrarenal angiotensin II and angiotensinogen augmentation in chronic angiotensin II-infused miceQ36877911
IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wastingQ37123224
Immunoregulators in the nervous systemQ37181575
The value of current interventions for obesityQ37200553
Neural networks of several novel neuropeptides involved in feeding regulationQ37251388
AMPK: a metabolic gauge regulating whole-body energy homeostasisQ37314854
The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasisQ37328877
Cardiac cachexia: a systematic overviewQ37343128
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanismQ37355630
Candesartan cilexetil in the treatment of chronic heart failureQ37479043
ACE inhibitors, angiotensin receptor blockers and direct renin inhibitors in combination: a review of their role after the ONTARGET trialQ37563491
Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers especially useful for cardiovascular protection?Q37629411
Renin-angiotensin-aldosterone blockade for cardiovascular disease preventionQ37831670
Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in miceQ39798655
Role of neuronal energy status in the regulation of adenosine 5'-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behaviorQ40514639
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wastingQ40891663
Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic optionsQ40896872
Anorexia during acute and chronic diseaseQ41047136
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review.Q41621710
Angiotensin II type 1 receptor signaling regulates feeding behavior through anorexigenic corticotropin-releasing hormone in hypothalamusQ42001876
Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinaseQ42491855
Elevated blood pressure in transgenic mice with brain-specific expression of human angiotensinogen driven by the glial fibrillary acidic protein promoterQ43709987
Role of AT2 receptor in the brain in regulation of blood pressure and water intakeQ44185525
Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signalingQ46291378
Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinaseQ46368505
Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptorQ46477287
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.Q46493539
Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neuronsQ46858899
Anticytokine approaches to the treatment of anorexia and cachexia.Q47979150
Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetateQ47979162
Inhibition by glucose or leptin of hypothalamic neurons expressing neuropeptide Y requires changes in AMP-activated protein kinase activityQ48375233
AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats.Q51372264
Circulating Renin Angiotensin System in Childhood Chronic Renal Failure: Marked Increase of Angiotensin-(1–7) in End-Stage Renal DiseaseQ56775014
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)1411-1420
P577publication date2012-01-10
P1433published inEndocrinologyQ3054009
P1476titleAngiotensin II reduces food intake by altering orexigenic neuropeptide expression in the mouse hypothalamus
P478volume153